Old Web
English
Sign In
Acemap
>
Paper
>
P-233Economic impact of biomarker-based anti EGFR therapies in metastatic colorectal cancer in Austria
P-233Economic impact of biomarker-based anti EGFR therapies in metastatic colorectal cancer in Austria
2015
D. Niedersuess-Beke
M. Schiffinger
R. Mader
Keywords:
Pathology
Medicine
Colorectal cancer
Biomarker (medicine)
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]